Raymond James Maintains Strong Buy on DexCom, Lowers Price Target to $131
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford maintains a Strong Buy rating on DexCom (NASDAQ:DXCM) but lowers the price target from $154 to $131.
September 15, 2023 | 11:24 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Despite the lowered price target from $154 to $131, Raymond James maintains a Strong Buy rating on DexCom.
The news is directly related to DexCom and is likely to influence investor sentiment. While the lowered price target might be seen as a negative, the maintained Strong Buy rating indicates that the analyst still sees significant upside potential in the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100